Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib
Authors:
- 17 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 87 (1) , 14-27
Abstract
Sorafenib was first approved as the standard treatment for advanced hepatocellular carcinoma (HCC). Despite providing an advantage in terms of patient survival, sorafenib has shown poor clinical efficacy and severe side effects after long-term treatment. Thus, combination treatment is a potential way to increase the effectiveness and reduce the dose-limiting toxicity of sorafenib. Extracts of the seeds of Annona montana have shown synergistic antitumor activity with sorafenib, and seven annonaceous acetogenins, including three new acetogenins, muricin P (2), muricin Q (3), and muricin R (4), were isolated from the extracts by bioguided fractionation and showed synergy with sorafenib. The structures of these compounds were determined using spectroscopic and chemical methods. Annonacin (1) and muricin P (2), which reduced intracellular ATP levels and promoted apoptosis, exhibited synergistic cytotoxicity with sorafenib in vitro. In vivo, annonacin (1) displayed synergistic antitumor activity by promoting tumor cell apoptosis. Moreover, the potential mechanism of annonacin (1) was predicted by transcriptomic analysis, which suggested that SLC33A1 is a potential target in HCC. Annonacin (1) might be a novel candidate for combination therapy with sorafenib against advanced HCC.Keywords
Funding Information
- National Natural Science Foundation of China (21672041)
This publication has 38 references indexed in Scilit:
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Practical Method for the Absolute Configuration Assignment of tert/tert 1,2-Diols Using Their Complexes with Mo2(OAc)4The Journal of Organic Chemistry, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of actionNatural Product Reports, 2005
- Novel Cytotoxic Annonaceous Acetogenins fromAnnonamuricataJournal of Natural Products, 2001
- Five Novel Mono-tetrahydrofuran Ring Acetogenins from the Seeds of Annona muricataJournal of Natural Products, 1996
- Annonaceous Acetogenins from the Seeds of Annona squamosa. Non-adjacent Bis-tetrahydrofuranic Acetogenins.Chemical and Pharmaceutical Bulletin, 1994
- Die relative Konfiguration der ausAnnona squamosaisolierten Acetogenine Annonin I (Squamocin) und Annonin VI1Planta Medica, 1990
- Annonacin, a novel, biologically active polyketide fromAnnona densicomaCellular and Molecular Life Sciences, 1987